Biologists have designed a programmable genetic 'circuit' which is capable of rewiring cells to respond on demand to any signal desired.

Christina Smolke, a bioengineer at Stanford University in California, constructed a stretch of DNA that acts as genetic circuit. When inserted into cells and transcribed into RNA, the circuit encodes its protein product only when it senses the presence or absence of a particular target protein inside the cell.
One version of the circuit makes human cells susceptible to an antiviral drug - but only if they are making abnormal amounts of a protein implicated in cancer.
To test their circuit, the researchers stimulated human cells to produce extra beta-catenin - as if they were cancer cells - then treated them with ganciclovir. Cells that contained the circuits were killed by the drug.
By tweaking the 'wiring' of such circuits, they could make cells respond to either the presence or absence of a desired protein, said Smolke.
Cell-hacking circuits are years away from the clinic, but Smolke thinks they could eventually be combined with other experimental treatments to control where and when they act within the body.
The study is published in Science.
MEDINDIA



Email








